About Jash Pharma Private Limited
Data last updated:
Jash Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2005PTC158290. Its GSTIN is 24AABCJ6230H1ZW (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Mudassar Haroon Makandar and Nazia Mudassar Makandar.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 302 B – Wing 3rd Floor Sumer Plaza Marol Maroshi Road Andheri East, Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2021, the company reported a revenue of ₹16.28 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹8.66 Lakh (net margin 0.5%) and EBITDA of ₹91.28 Lakh (EBITDA margin 5.6%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 2% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Jash Pharma. As per MCA filings, the company has open charges of ₹7.1 Cr and satisfied charges of ₹10.55 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jashpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address302 B – Wing 3rd Floor Sumer Plaza Marol Maroshi Road Andheri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Jash Pharma Private Limited
Jash Pharma operates one associated brand: Jash Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers professional commercial cleaning for offices and facilities in Florida. | jashpharma.com |
Competitors & Alternatives of Jash Pharma Private Limited
Brands and companies operating in the same space as Jash Pharma Private Limited include Inventia Healthcare, Zim Labs, Lotus and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Inventia Healthcare | Oral solid drug delivery systems are manufactured and developed. | Mumbai, India | 1985 |
 Zim Labs | Solid and semisolid dosage forms are developed and manufactured. | Nagpur, India | 1989 |
 Lotus | Contract manufacturing for oral solid formulations is offered. | Taipei, Taiwan | 1966 |
 Contract Pharmacal Corp. | Product development, manufacturing and packaging services | Hauppauge, United States | 1971 |
 Adare Pharma Solutions | CDMO manufacturing solid drugs | Lawrence Township, United States | 2015 |
 Suzhou Ze Jing Biological Pharmaceutical | Company developing small molecules & eukaryotic cell based recombinant protein drugs | Suzhou, China | 2009 |
 Halewood Laboratories | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. | Ahmedabad, India | 1984 |
 Capsugel | Dosage forms are delivered for preclinical, clinical, and commercial supply. | Morristown, United States | 1875 |
 Glukem | Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. | Hyderabad, India | 2014 |
 Vovantis Laboratories | Develops and manufactures novel effervescent drug delivery systems. | Vadodara, India | 2008 |
Business Activity of Jash Pharma Private Limited
The main business activity of Jash Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Jash Pharma Private Limited
Jash Pharma Private Limited is audited by JAY PAREKH & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAY PAREKH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Jash Pharma Private Limited
Jash Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mudassar Haroon Makandar Also directs: Jwell Healthcare Private Limited, Derive Tours and Travels Private Limited, Vashishth Tech Enterprise Private Limited and 1 more | Director | 26 Nov 2019 | 6 Years 10 Months | Current |
| Nazia Mudassar Makandar | Director | 02 Feb 2024 | 2 Years 8 Months | Current |
Financials of Jash Pharma Private Limited FY 2021 filings available
Jash Pharma Private Limited reported revenue of ₹16.28 Cr (up 24% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Jash Pharma Private Limited
Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Jash Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹16.28 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹91.28 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.66 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Jash Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jash Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Jash Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Jash Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2014 | Others | ₹7.1 Cr | Open |
| 22 Jul 2014 | Janata Sahakari Bank Ltd Pune | ₹6.75 Cr | Satisfied |
| 18 Jan 2007 | Indian Bank | ₹2 Cr | Satisfied |
| 15 Jan 2007 | Indian Bank | ₹1.8 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Jash Pharma Private Limited
Jash Pharma Private Limited has a workforce of 27 employees as of Jan 17, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Jash Pharma Private Limited
Jash Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCJ6230H1ZW | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Jash Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Jash Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jash Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jash Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Jash Pharma Private Limited
Frequently Asked Questions about Jash Pharma Private Limited
Jash Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 December 2005 (21+ years old) and is registered under CIN U24239MH2005PTC158290.
Jash Pharma reported revenue of ₹16.28 Cr for FY 2021 (up 24% YoY).
Jash Pharma has 2 current directors:
- Mudassar Haroon Makandar - Director
- Nazia Mudassar Makandar - Director
Jash Pharma reported a net profit of ₹8.66 Lakh (net margin 0.5%) and EBITDA of ₹91.28 Lakh (EBITDA margin 5.6%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Jash Pharma is -28% over three years and -2% over five years. In the latest year (FY 2021) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Jash Pharma is 24AABCJ6230H1ZW, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Jash Pharma is U24239MH2005PTC158290. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jash Pharma was incorporated on 20 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Jash Pharma can be reached through the website jashpharma.com. Its registered office is in Mumbai, Maharashtra, India.